Integra Lifesciences Holdings (IART) EPS (Diluted) Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) EPS (Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 13.96% |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 100.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.91% |
| Mar 31, 2026 | 81.86% |
| Dec 31, 2025 | -108.81% |
| Sep 30, 2025 | 49.67% |
| Jun 30, 2025 | -3,839.52% |
| Mar 31, 2025 | -683.72% |
| Dec 31, 2024 | 2.22% |
| Sep 30, 2024 | -157.27% |
| Jun 30, 2024 | -410.74% |
| Mar 31, 2024 | -114.34% |
| Dec 31, 2023 | -61.06% |
| Sep 30, 2023 | -59.18% |
| Jun 30, 2023 | -90.37% |
| Mar 31, 2023 | -24.62% |
| Dec 31, 2022 | 19.41% |
| Sep 30, 2022 | 18.30% |
| Jun 30, 2022 | 30.34% |
| Mar 31, 2022 | -26.68% |
| Dec 31, 2021 | -51.21% |
| Sep 30, 2021 | 32.60% |